4 mM of dNTP, 1 U of Taq polymerase (Invitrogen) and 10 ng of gen

4 mM of dNTP, 1 U of Taq polymerase (Invitrogen) and 10 ng of genomic DNA. The amplification conditions were: 95°C for 5 min, followed by 30 cycles of denaturation at 95°C for 30 sec; annealing at 55°C for 30 sec; extension at 72°C for 2 min; final extension at 72°C for 5 min. Amplicons were electrophoresed in 1.5% agarose in 20 mM Tris, 20 mM acetic acid, 1 mM EDTA, and detected with ethidium bromide. Cloning and sequence analysis Specific IS-anchored and flanking PCR products

purified from gels were cloned into the pCR2.1 vector (Invitrogen) and sequenced by fluorescence-labeled dideoxynucleotide technology (Macrogen Inc, Seoul, South Korea). Sequences were analyzed by BLASTN (http://​www.​ncbi.​nlm.​nih.​gov/). Comparison of the IS711 sequences in the B. abortus 9-941 JNK-IN-8 genome (accession

numbers AE017223 and AE017224) [4] AC220 clinical trial and the new IS711 was performed with ClustalW2 (http://​www.​ebi.​ac.​uk/​Tools/​clustalw2). Sequences of BIX 1294 cell line new IS711 were deposited under GenBank accession numbers: JF345125 and JF345126. Construction of B. abortus 2308 ΔmarR mutant A B. abortus 2308 NalR ΔmarR non polar mutant was constructed by allelic exchange [21] with primers designed on the sequence of marR (BAB2_0468, the marR homologous). Briefly, two fragments generated with primer pairs marR-F1, R2 and marR-F3, R4 (Table 2) were ligated by overlapping PCR and the resulting fragment (containing a ΔmarR lacking the nucleotides corresponding to amino acids 13-120) was cloned into pCR2.1 to produce plasmid pMM19 (Additional file 2). The BamHI-NotI fragment of pMM19 was subcloned into plasmid pJQK [22] to generate the pMM21 suicide vector (Additional file 2), which was transferred to B. abortus 2308 NalR by conjugation with a suitable E. coli strain [23]. Nalidixic acid and sucrose resistant clones were screened by PCR, and tested for urease [17]. Acknowledgements and funding We thank Servicio

Agrícola y Ganadero de Chile (SAG) for providing Brucella strains.This work was Resveratrol funded by FONDEF D02I 1111, CONICYT-FIC-R-EQU18, the Department of Research and Development at Universidad Austral de Chile, project S-2009-33 and Ministerio de Ciencia y Tecnología of Spain (AGL2008-04514). MM was supported by CONICYT-Ph.D. fellowship (Chile) and PIUNA grant (Universidad de Navarra). Electronic supplementary material Additional file 1: PCR analysis for the presence of x-B16 fragment in B. ovis, B. ceti and B. pinnipedialis. Additional file 1 is a word file displaying a picture of PCR results. (DOC 234 KB) Additional file 2: E. coli strains and plasmids. Additional file 2 is a word file displaying a table with E. coli strains and plasmids used in this work. (DOC 36 KB) References 1. Halling SM, Tatum FM, Bricker BJ: Sequence and characterization of an insertion sequence, IS 711 , from Brucella ovis . Gene 1993,133(1):123–127.PubMedCrossRef 2.

Comments are closed.